Oculis
Clinical trials sponsored by Oculis, explained in plain language.
-
New drug aims to save sight in optic neuritis patients
Disease control Recruiting nowThis Phase 3 trial tests whether privosegtor, a neuroprotective drug, can improve vision recovery in people having their first episode of optic neuritis. About 210 adults aged 18 to 50 will receive either privosegtor or a placebo, both alongside standard steroid treatment. The ma…
Phase: PHASE3 • Sponsor: Oculis • Aim: Disease control
Last updated Jul 02, 2026 05:00 UTC
-
New eye drop targets dry eye by gene type
Symptom relief Recruiting nowThis study tests whether licaminlimab eye drops can reduce eye discomfort in people with dry eye disease who have a specific gene variant. About 160 participants will use the drops three times daily for 29 days. The goal is to see if this targeted approach works better than a pla…
Phase: PHASE2, PHASE3 • Sponsor: Oculis • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC